TrialCancer immunology research2014

A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer.

Gang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.